PTBP1 and proximal spinal muscular atrophy: In addition to PTBP1−knockdown, masking the PTBP1 cis−elements by antisense oligonucleotide (ASO) would be a possible therapeutic modality, as used in the treatment of SMA against the cis−element for hnRNP A1 [47].